Open AccessRefractive surgery for the patient with autoimmune diseases
Author(s) -
Tony Y. Chen,
David Chu
Publication year - 2020
Publication title -
current opinion in ophthalmology, with evaluated medline/current opinion in ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.371
H-Index - 86
eISSN - 1080-8132
pISSN - 1040-8738
DOI - 10.1097/icu.0000000000000668
Subject(s) - medicine , guideline , rheumatoid arthritis , refractive surgery , spondyloarthropathy , intensive care medicine , medline , population , dermatology , ophthalmology , immunology , cornea , pathology , environmental health , political science , law
Autoimmune and immune-mediated diseases are considered contraindications for laser refractive surgeries according to the US Food and Drug Administration's guideline. This guideline, however, is based on limited case reports or complications reported during other intraocular procedures. There have been only a handful of new clinical studies that evaluate the efficacy and safety of refractive surgery in this specific patient population. The aim of this article is to review currently available research and offer updated recommendations for the evaluation and management of laser refractive surgery (LRS) in patients with autoimmune diseases.